Haptoglobin
Haptoglobin is a glycoprotein produced mainly in the liver. It has capacity to bind free hemoglobin released in the circulation, thus preventing iron loss and renal damage during hemolysis {red blood cell destruction}. When the hemoglobin-binding capacity of haptoglobin is exceeded (concentration of released free hemoglobin exceeds that of haptoglobin) plasma free hemoglobin is present and hlemoglobinemia and hemoglobinuria results. Haptoglobin also acts as an antioxidant, has antibacterial activity, and plays a role in modulating many aspects of the acute phase response. Haptoglobin is one of the acute phase proteins and levels rise with inflammatory states. Some think that the role of haptoglobin is to modulate the inflammatory reaction. Haptoglobin testing along with an RBC count, Hgb (hemoglobin), and Hct (hematocrit) are critical in diagnosing hemolytic anemia. There are major haptoglobin phenotypes Hp(1-1), Hp(2-1), and Hp(2-2). Possession of a particular phenotype has been associated with a variety of common disorders (e.g. cardiovascular disease, autoimmune disorders, malignancy), a fact which can only be explained by the idea that possession of a particular phenotype offers some protection against the development of these disorders. Knowledge of a patient’s phenotype could therefore aid in the prognosis of disease and allow treatment to be better tailored to suit the individuals' needs.
- Diagnostically used to detect episodes of hemolysis
- As an aid in diagnosis of megaloblastic anemias
- As an aid in diagnosis of hemoglobinopathies
- As an aid in diagnosis of hematomas and hemorrhage
Increased in:
- Infection
- Malignancy
- Biliary obstruction
- Ulcerative colitis
- Myocardial infarction
- Diabetes mellitus
Decreased in:
- Newborns and children
- Post transfusion intravascular hemolysis
- Hemolysis of any etiology
- Autoimmune hemolytic anemia
- Liver disease
- Pregnancy
- Estrogen therapy
- May be decreased following uneventful transfusion (10%) for unknown reasons.
| Group | mg/dL | mg/L |
| Newborn | 5–48 | 50–480 |
| Adult | 26–185 | 260–1850 |
| >60 yr Male | 35–164 | 350–1640 |
| >60 yr Female | 40–175 | 400–1750 |
Serum (SST).
Stability
- Ambient: 48 hours
- Refrigerated: 7 days
- Frozen: 90 days
- Cardiovasc Diabetol. 2011 Nov 20;10:99. [PMID: 22098782]
- J Perinat Med. 2000;28:249. [PMID: 11031696]
- Clin Lab. 2000;46(11-12):547-52. [PMID: 11109501]
- Am J Clin Pathol. 2004 Jun;121 Suppl:S97-104. [PMID: 15298155]
- Am J Clin Pathol. 2004;121:S97. [PMID: 15298155]
- Jacobs DS, DeMott WR. Laboratory Test Handbook. 5th. Hudson, OH. Lexi-Comp, Inc (2001).